Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Does natalizumab therapy worsen neuromyelitis optica?
Altered lipid levels provide evidence for myelin dysfunction in multiple system atrophy.
Modulation of a pore in the capsid of JC polyomavirus reduces infectivity and prevents exposure of the minor capsid proteins.
Teva and Active Biotech Announce Completion of Patient Enrollment in Laquinimod Phase III CONCERTO Trial
Pathogenesis of multiple sclerosis: insights from molecular and metabolic imaging.
The onset location of neuromyelitis optica spectrum disorder predicts the location of subsequent relapses.
The effect of scheduled antibody testing on treatment patterns in interferon-treated patients with multiple sclerosis.
Suicide risk in multiple sclerosis: A systematic review of current literature.
Axial 3D gradient-echo imaging for improved multiple sclerosis lesion detection in the cervical spinal cord at 3T.
Attenuation of corpus callosum axon myelination and remyelination in the absence of circulating sex hormones.
Altered expression of the plasminogen activation pathway in peripheral blood mononuclear cells in multiple sclerosis: possible pathomechanism of matrix metalloproteinase activation.
The role of the immune system in the generation of neuropathic pain.
CC3-03: Drug Characteristics Associated with Medication Adherence Across Eight Disease States.
Oligoclonal bands and cerebrospinal fluid markers in multiple sclerosis: associations with disease course and progression.
Safety and Efficacy Study of Copaxone Administered in Combination With Minocycline
A polysaccharide from the human commensal Bacteroides fragilis protects against CNS demyelinating disease.
Hematopoietic mobilization: Potential biomarker of response to natalizumab in multiple sclerosis.
Potent and orally efficacious bisthiazole-based histone deacetylase inhibitors.
Uveitis as a prognostic factor in multiple sclerosis.
Music mnemonics aid Verbal Memory and Induce Learning - Related Brain Plasticity in Multiple Sclerosis.
Early onset multiple sclerosis has worse prognosis than adult onset multiple sclerosis based on cognition and magnetic resonance imaging.
Influence of fingolimod on basic lymphocyte subsets frequencies in the peripheral blood of multiple sclerosis patients - preliminary study.
Torque teno virus (TTV) in multiple sclerosis patients with different patterns of disease.
The neurology of Sjogren's syndrome and the rheumatology of peripheral neuropathy and myelitis.
Olig1 function is required for remyelination potential of transplanted neural progenitor cells in a model of viral-induced demyelination.
Pages
« first
‹ previous
…
233
234
235
236
237
238
239
240
241
…
next ›
last »